Vor Biopharma Inc. - VOR

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 14, 2026 SCHEDULE 13G/A Venrock Healthcare Capital Partners III, L.P. 9.9% 5,676,370 View
Aug 14, 2026 SCHEDULE 13G/A VHCP Co-Investment Holdings III, LLC 9.9% 5,676,370 View
Aug 14, 2026 SCHEDULE 13G/A Venrock Healthcare Capital Partners EG, L.P. 9.9% 5,676,370 View
Aug 14, 2026 SCHEDULE 13G/A VHCP Management III, LLC 9.9% 5,676,370 View
Aug 14, 2026 SCHEDULE 13G/A VHCP Management EG, LLC 9.9% 5,676,370 View
Aug 14, 2026 SCHEDULE 13G/A Nimish Shah 9.9% 5,676,370 View
Aug 14, 2026 SCHEDULE 13G/A Bong Y. Koh 9.9% 5,676,370 View
Aug 14, 2026 SCHEDULE 13G/A Frazier Life Sciences Public Fund, L.P. 4.2% 2,258,001 View
Aug 14, 2026 SCHEDULE 13G/A FHMLSP, L.P. 4.2% 2,258,001 View
Aug 14, 2026 SCHEDULE 13G/A FHMLSP, L.L.C. 4.2% 2,258,001 View
Aug 14, 2026 SCHEDULE 13G/A Frazier Life Sciences XI, L.P. 0.0% 21,114 View
Aug 14, 2026 SCHEDULE 13G/A FHMLS XI, L.P. 0.0% 21,114 View
Aug 14, 2026 SCHEDULE 13G/A FHMLS XI, L.L.C. 0.0% 21,114 View
Aug 14, 2026 SCHEDULE 13G/A Frazier Life Sciences XII, L.P. 0.5% 264,824 View
Aug 14, 2026 SCHEDULE 13G/A FHMLS XII, L.P. 0.5% 264,824 View
Aug 14, 2026 SCHEDULE 13G/A FHMLS XII, L.L.C. 0.5% 264,824 View
Aug 13, 2026 SCHEDULE 13G/A Verve Capital Limited 6.3% 3,410,892 View
Aug 07, 2026 SCHEDULE 13G/A FMR LLC 12.0% 6,509,996 View
Aug 07, 2026 SCHEDULE 13G/A Abigail P. Johnson 12.0% 6,509,996 View
Aug 06, 2026 SCHEDULE 13G FMR LLC 9.1% 4,932,149 View
Aug 06, 2026 SCHEDULE 13G Abigail P. Johnson 9.1% 4,932,149 View
Jul 21, 2026 SCHEDULE 13D/A — 19.9% — View
May 15, 2026 SCHEDULE 13G/A Venrock Healthcare Capital Partners III, L.P. 9.9% 5,083,877 View
May 15, 2026 SCHEDULE 13G/A VHCP Co-Investment Holdings III, LLC 9.9% 5,083,877 View
May 15, 2026 SCHEDULE 13G/A Venrock Healthcare Capital Partners EG, L.P. 9.9% 5,083,877 View
May 15, 2026 SCHEDULE 13G/A VHCP Management III, LLC 9.9% 5,083,877 View
May 15, 2026 SCHEDULE 13G/A VHCP Management EG, LLC 9.9% 5,083,877 View
May 15, 2026 SCHEDULE 13G/A Nimish Shah 9.9% 5,083,877 View
May 15, 2026 SCHEDULE 13G/A Bong Y. Koh 9.9% 5,083,877 View
May 15, 2026 SCHEDULE 13G/A Verve Capital Limited 9.3% 4,999,272 View
May 06, 2026 SCHEDULE 13G/A Qiming Venture Partners VIII-HC, L.P. 2.0% 1,089,767 View
May 06, 2026 SCHEDULE 13G/A Qiming Venture Partners VIII Investments, LLC 1.7% 910,172 View
May 06, 2026 SCHEDULE 13G/A Qiming GP VIII, LLC 1.7% 910,172 View
May 06, 2026 SCHEDULE 13G/A Qiming GP VIII-HC, LLC 2.0% 1,089,767 View
May 06, 2026 SCHEDULE 13G/A FMR LLC 3.2% 1,539,670 View
May 06, 2026 SCHEDULE 13G/A Abigail P. Johnson 3.2% 1,539,670 View
Apr 21, 2026 SCHEDULE 13D/A — 19.9% — View
Apr 15, 2026 SCHEDULE 13D/A — 19.9% — View
Apr 10, 2026 SCHEDULE 13D/A — 19.9% — View
Apr 08, 2026 SCHEDULE 13D/A — 19.9% — View
Apr 01, 2026 SCHEDULE 13G TCG Crossover GP II, LLC 5.2% 2,836,539 View
Apr 01, 2026 SCHEDULE 13G TCG Crossover Fund II, L.P. 5.2% 2,836,539 View
Apr 01, 2026 SCHEDULE 13G TCG Crossover GP III, LLC 5.2% 2,836,539 View
Apr 01, 2026 SCHEDULE 13G TCG Crossover Fund III, L.P. 5.2% 2,836,539 View
Apr 01, 2026 SCHEDULE 13G Chen Yu 10.5% 5,673,078 View
Apr 01, 2026 SCHEDULE 13D/A — 19.9% — View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.